This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Find out more about how we use cookies and how to manage them by reading our cookie notice.

Lorraine Webber

Senior Director Emerging Innovations

Lorraine Webber is the UK Head of the Emerging Innovations Unit within AstraZeneca R&D. This is an externally-focussed R&D team primarily involved in drug re-purposing through pioneering ‘open innovation’ partnerships with a global network of external investigators, as well as internal drug repositioning. Lorraine has a broad background in drug development and has led drug projects in early clinical phase development in a number of therapy areas including respiratory, dermatology and women’s health. Lorraine has also held roles in the global commercial organisations at AstraZeneca and Novartis. Lorraine holds a degree in Medicine from Guy’s and St. Thomas’s Hospitals, London.

You are viewing: All posts Reset filters

Our Other Authors